BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 10534403)

  • 1. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region.
    Li Q; Zhang M; Duan Z; Stamatoyannopoulos G
    Genomics; 1999 Oct; 61(2):183-93. PubMed ID: 10534403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythroid AP-1/NF-E2 elements vary in their response to NF-E2.
    Walters M; Andrews NC; Magis W; Martin DI
    Exp Hematol; 1996 Feb; 24(3):445-52. PubMed ID: 8599974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2.
    Peters LL; Andrews NC; Eicher EM; Davidson MB; Orkin SH; Lux SE
    Nature; 1993 Apr; 362(6422):768-70. PubMed ID: 8469289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complete sequences of the galago and rabbit beta-globin locus control regions: extended sequence and functional conservation outside the cores of DNase hypersensitive sites.
    Slightom JL; Bock JH; Tagle DA; Gumucio DL; Goodman M; Stojanovic N; Jackson J; Miller W; Hardison R
    Genomics; 1997 Jan; 39(1):90-4. PubMed ID: 9027490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region.
    Stamatoyannopoulos JA; Goodwin A; Joyce T; Lowrey CH
    EMBO J; 1995 Jan; 14(1):106-16. PubMed ID: 7828582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomous, erythroid-specific DNase I hypersensitive site formed by human beta-globin locus control region (LCR) 5' HS 2 in transgenic mice.
    Pawlik KM; Townes TM
    Dev Biol; 1995 Jun; 169(2):728-32. PubMed ID: 7781911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing.
    Iler N; Goodwin AJ; McInerney J; Nemeth MJ; Pomerantz O; Layon ME; Lowrey CH
    Blood Cells Mol Dis; 1999 Feb; 25(1):47-60. PubMed ID: 10349513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of chromatin structure on bleomycin-DNA interactions at base pair resolution in the human beta-globin gene cluster.
    Cairns MJ; Murray V
    Biochemistry; 1996 Jul; 35(26):8753-60. PubMed ID: 8679639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus.
    Shyu YC; Lee TL; Ting CY; Wen SC; Hsieh LJ; Li YC; Hwang JL; Lin CC; Shen CK
    Mol Cell Biol; 2005 Dec; 25(23):10365-78. PubMed ID: 16287851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and characterization of the mouse alpha-globin locus control region.
    Kielman MF; Smits R; Bernini LF
    Genomics; 1994 May; 21(2):431-3. PubMed ID: 8088839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
    Gui CY; Dean A
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein.
    Andrews NC; Erdjument-Bromage H; Davidson MB; Tempst P; Orkin SH
    Nature; 1993 Apr; 362(6422):722-8. PubMed ID: 8469283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroid regulatory elements.
    Raich N; Romeo PH
    Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved elements containing NF-E2 and tandem GATA binding sites are required for erythroid-specific chromatin structure reorganization within the human beta-globin locus control region.
    Pomerantz O; Goodwin AJ; Joyce T; Lowrey CH
    Nucleic Acids Res; 1998 Dec; 26(24):5684-91. PubMed ID: 9838000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
    Armstrong JA; Emerson BM
    Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes.
    Deveaux S; Cohen-Kaminsky S; Shivdasani RA; Andrews NC; Filipe A; Kuzniak I; Orkin SH; Roméo PH; Mignotte V
    EMBO J; 1997 Sep; 16(18):5654-61. PubMed ID: 9312024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer.
    Reddy PM; Shen CK
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8676-80. PubMed ID: 1924329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple elements in human beta-globin locus control region 5' HS 2 are involved in enhancer activity and position-independent, transgene expression.
    Caterina JJ; Ciavatta DJ; Donze D; Behringer RR; Townes TM
    Nucleic Acids Res; 1994 Mar; 22(6):1006-11. PubMed ID: 8152905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large upstream region is not necessary for gene expression or hypersensitive site formation at the mouse beta -globin locus.
    Farrell CM; Grinberg A; Huang SP; Chen D; Pichel JG; Westphal H; Felsenfeld G
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14554-9. PubMed ID: 11121056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.